Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -1.57% is 106% below its 5-year average of 24.82%, near the low end of its 5-year range (-1.57%–37.60%).
109.01% below its 12-month average of 17.43%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 7.09%.
RETURN ON ASSETS (ROA)
-1.57%
RETURN ON ASSETS (ROA) AVG TTM
17.43%
RETURN ON ASSETS (ROA) AVG 3Y
19.75%
RETURN ON ASSETS (ROA) AVG 5Y
24.82%
RETURN ON ASSETS (ROA) AVG 10Y
25.61%
RETURN ON ASSETS (ROA) AVG 15Y
5.14%
RETURN ON ASSETS (ROA) AVG 20Y
-19.19%
CURRENT VS TTM AVG
-109.01%
CURRENT VS 3Y AVG
-107.95%
CURRENT VS 5Y AVG
-106.33%
CURRENT VS 10Y AVG
-106.13%
CURRENT VS 15Y AVG
-130.56%
CURRENT VS 20Y AVG
+91.82%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+95.13%
vs the sector median at left
SIGA Technologies, Inc.
Market Cap
$232.74M
Return on Assets (ROA)
-1.57%
TTM Avg
17.43%
3Y Avg
19.75%
5Y Avg
24.82%
Market Cap
$233.46M
Return on Assets (ROA)
-23.88%
TTM Avg
-71.64%
3Y Avg
-51.89%
5Y Avg
-47.09%
Market Cap
$225.89M
Return on Assets (ROA)
-29.12%
TTM Avg
-42.23%
3Y Avg
-51.88%
5Y Avg
-48.35%
Market Cap
$235.83M
Return on Assets (ROA)
8.42%
TTM Avg
10.27%
3Y Avg
11.53%
5Y Avg
11.43%
Market Cap
$229.29M
Return on Assets (ROA)
-23.80%
TTM Avg
-23.59%
3Y Avg
-108.30%
5Y Avg
-108.30%
Market Cap
$236.23M
Return on Assets (ROA)
-8.48%
TTM Avg
-16.43%
3Y Avg
-20.20%
5Y Avg
-32.31%
Market Cap
$235.95M
Return on Assets (ROA)
-114.79%
TTM Avg
-67.19%
3Y Avg
-63.94%
5Y Avg
-45.91%
Market Cap
$236.83M
Return on Assets (ROA)
-49.04%
TTM Avg
-75.08%
3Y Avg
-74.95%
5Y Avg
-71.96%
Market Cap
$228.51M
Return on Assets (ROA)
-4.22%
TTM Avg
-27.32%
3Y Avg
-24.76%
5Y Avg
-32.27%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SIGA Technologies, Inc. (SIGA) | $232.74M | -1.57% | 17.43% | 19.75% | 24.82% |
| InflaRx N.V. (IFRX)vs › | $233.46M | -23.88% | -71.64% | -51.89% | -47.09% |
| Biodesix, Inc. (BDSX)vs › | $225.89M | -29.12% | -42.23% | -51.88% | -48.35% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.83M | 8.42% | 10.27% | 11.53% | 11.43% |
| BioAge Labs Inc. (BIOA)vs › | $229.29M | -23.80% | -23.59% | -108.30% | -108.30% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.23M | -8.48% | -16.43% | -20.20% | -32.31% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $235.95M | -114.79% | -67.19% | -63.94% | -45.91% |
| Invivyd, Inc. (IVVD)vs › | $236.83M | -49.04% | -75.08% | -74.95% | -71.96% |
| MacroGenics, Inc. (MGNX)vs › | $228.51M | -4.22% | -27.32% | -24.76% | -32.27% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $227.79M | -34.55% | -30.02% | -24.36% | -21.40% |
ROA
-1.6%
ROE
-1.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 10.62% |
| 2024-12-31 | 24.23% |
| 2023-12-31 | 26.76% |
| 2022-12-31 | 17.38% |
| 2021-12-31 | 32.34% |
| 2020-12-31 | 37.60% |
| 2019-12-31 | -3.65% |
| 2018-12-31 | 207.33% |
| 2017-12-31 | -25.05% |
| 2016-12-31 | -24.66% |
| 2015-12-31 | -21.24% |
| 2014-12-31 | -159.55% |
| 2013-12-31 | -8.86% |
| 2012-12-31 | -13.73% |
| 2011-12-31 | 15.04% |
| 2010-12-31 | -104.30% |
| 2009-12-31 | -67.98% |
| 2008-12-31 | -97.75% |
| 2007-12-31 | -53.25% |
| 2006-12-31 | -70.57% |
| 2005-12-31 | -37.47% |
| 2004-12-31 | -153.39% |
| 2003-12-31 | -86.51% |
| 2002-12-31 | -117.70% |
| 2001-12-31 | -88.64% |
| 2000-12-31 | -242.65% |
| 1999-12-31 | -105.88% |
| 1998-12-31 | -92.96% |
| 1997-12-31 | -19.82% |
| 1996-12-31 | -383.33% |
